Ratings 2CRSi

Equities

AL2SI

FR0013341781

Market Closed - Euronext Paris 11:35:29 2024-04-29 am EDT 5-day change 1st Jan Change
3.57 EUR -1.65% Intraday chart for 2CRSi +0.28% +138.00%

Strengths

  • Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 75% by 2026.
  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.64 for the 2024 fiscal year.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Over the past four months, analysts' average price target has been revised upwards significantly.
  • Analyst opinion has improved significantly over the past four months.
  • Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 60.5 times its estimated earnings per share for the ongoing year.
  • The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Computer Hardware

1st Jan change Capi. Investor Rating ESG Refinitiv
+138.00% 73.68M
C
+66.93% 89.27B
B-
-6.05% 27.4B
B-
+1.18% 22.32B
B
+0.83% 18.07B
C-
-17.58% 14.31B
B-
-8.75% 12.3B
A-
+10.54% 10.03B
C
+15.62% 9.94B
A-
-12.97% 9.54B
B-
Investor Rating
Trading Rating
-
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
-
4 months Revenue revision
-
7 days Revenue revision
1 year EPS revision
-
4 months EPS revision
-

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes